Yes, and hopefully they can even manage an abbreviated 510k which is a pathway you would use for a major update or feature rather than a new product. For a new product they would be doing a 510k where their own ResAppDx is the predicate device and they are demonstrating that the new product is substantially equivalent. This is a shoe in but still a lot of paperwork compared to the abbreviated 510k pathway.
- Forums
- ASX - By Stock
- 2020 The Year Of RAP
Yes, and hopefully they can even manage an abbreviated 510k...
-
- There are more pages in this discussion • 244 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
|
|||||
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $176.2M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
RAP (ASX) Chart |
Day chart unavailable